Meeting
2016 ASCO Annual Meeting
Development of nationwide genomic screening project (LC-SCRUM-Japan) contributing to the establishment of precision medicine in Japan.
Authors
Takuma Yokoyama
Kyorin University Hospital, Mitakashi, Japan
Takuma Yokoyama , Shingo Matsumoto , Kiyotaka Yoh , Takashi Seto , Haruyasu Murakami , Eiji Iwama , Yuichiro Ohe , Masato Shingyoji , Kadoaki Ohashi , Koji Takeda , Yoshihiro Hattori , Shunichi Sugawara , Sho Saeki , Tomoya Fukui , Makoto Nishio , Masahiro Kodani , Takashi Kohno , Koji Tsuta , Katsuya Tsuchihara , Koichi Goto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9089)
DOI
10.1200/JCO.2016.34.15_suppl.9089
Abstract #
9089
Poster Bd #
412
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Contribution of nationwide genome screening in Japan (LC-SCRUM-Japan) to the development of precision medicine for non-small cell lung cancer.
First Author: Takashi Seto
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2015 ASCO Annual Meeting
Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).
First Author: Shingo Matsumoto
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon